Seattle Biomed gets $9m from Gates to boost malaria vaccine work

Luke Timmerman of Xconomy reports today that Seattle Biomed, a global leader in malaria research thanks to funding from the Bill & Melinda Gates Foundation, has gotten a boost.

In the article, Timmerman notes that the $9 million grant is aimed at supporting a “systems biology” approach to identify new immune system targets for candidate vaccines. In that sense, it is also a Gates grant aimed at supporting the work of Alan Aderem, who is moving his lab there from Lee Hood’s Institute for Systems Biology:

Seattle Biomed made a push in the direction of systems biology—which seeks to study whole biological organisms in context, rather than one gene or protein in isolation—last month. The nonprofit recruited Aderem, the co-founder of the Institute for Systems Biology, to help infuse its global health research efforts with this bold brand of science.

Share.

About Author

Tom Paulson

Tom Paulson is founder and lead journalist at Humanosphere. Prior to operating this online news site, he reported on science,  medicine, health policy, aid and development for the Seattle Post-Intelligencer. Contact him at tom[at]humanosphere.org, follow him on Twitter @tompaulson and/or send a comment below.